Figure 3
Figure 3. Outcomes stratified by combined WT1 and FLT3/ITD mutation status. When stratifying patients by combined FLT3/ITD and WT1 status, patients with both mutations had the worst (A) OS, (B) EFS, and (C) RR. Of the 2 mutations, FLT3/ITD imparts a stronger negative effective on survival outcome.

Outcomes stratified by combined WT1 and FLT3/ITD mutation status. When stratifying patients by combined FLT3/ITD and WT1 status, patients with both mutations had the worst (A) OS, (B) EFS, and (C) RR. Of the 2 mutations, FLT3/ITD imparts a stronger negative effective on survival outcome.

Close Modal

or Create an Account

Close Modal
Close Modal